Masaki Hisao, Tabuchi Atushi, Yunoki Yasuhiro, Kubo Hiroshi, Nishikawa Kosaku, Yakiuchi Hiroki, Tanemoto Kazuo
Division of Cardiovascular Surgery, Department of Surgery, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Ann Vasc Dis. 2013;6(1):27-32. doi: 10.3400/avd.oa.12.00107. Epub 2013 Feb 15.
To determine a treatment strategy based on the outcomes of various previous interventions for critical limb ischemia in arteriosclerosis obliterans (ASO).
We examined outcomes of 292 ASO patients who had had critical limb ischemia between May 1995 and July 2009. Patients underwent the following procedures in 167 cases: aortofemoral bypass (n = 14), femorofemoral crossover bypass (n = 29), femoropopliteal bypass (n = 104) and femorotibial bypass (n = 40). Other procedures included bypass only (n = 147), bypass combined with thromboendarterectomy (n = 10), bypass combined with endovascular therapy (n = 6), bypass combined with lumbar sympathectomy (n = 2), endovascular therapy combined with thromboendarterectomy (n = 4), endovascular therapy (n = 19), lumbar sympathectomy (n = 6), conservative therapy (n = 65), and major amputation (n = 31). We also calculated P3 risk scores and measured transcutaneous oxygen pressure (tcPO2) and skin perfusion pressure (SPP) before and after therapy.
The limb salvage rate was 87% at 2 years in the arterial reconstruction group. In the low-risk group (a P 3 risk score of 3), the 1-year amputation-free survival rate was 96%. In the medium-risk group (a P 3 risk score of 4-7), the 1-year amputation-free survival rate was 88%. In the high-risk group (a P 3 risk score of 8), the 1-year amputation-free survival rate was 66%. The hospital death rate in the arterial reconstruction group was 3.2%, all of whom were patients who underwent bypass. The survival rate at 5 years was 65% and 36% in the conservative therapy only group. Ulcers healed in 140 out of 144 patients. The 4 patients with unhealed infections had tcPO2 or SPP values of more than 30 mmHg after treatment. Major amputations were performed in 4 of 5 patients who had tcPO2 or SPP values from 20 to 30 mmHg after treatment. Major amputations were performed in all 6 patients who had tcPO2 or SPP values of less than 20 mmHg after treatment.
In cases with tcPO2 or SPP values of more than 30 mmHg, an ulcer will probably heal, except in infected cases. We suggest that, if these values are less than 30 mmHg, complete revascularization should be performed. The P3 risk score was useful in predicting limb salvage in the current series. Hybrid therapy in bypass and endovascular therapy must be performed in cases where patients are in a generally poor condition. It is important to attempt amelioration in limb salvage and to control the operative mortality rate with sufficient perioperative control. (English Translation of Jpn J Vasc Surg 2011;20:905-911).
根据既往对动脉硬化闭塞症(ASO)所致严重肢体缺血的各种干预措施的结果确定一种治疗策略。
我们研究了1995年5月至2009年7月期间292例患有严重肢体缺血的ASO患者的治疗结果。167例患者接受了以下手术:主-股动脉搭桥术(n = 14)、股-股交叉搭桥术(n = 29)、股-腘动脉搭桥术(n = 104)和股-胫动脉搭桥术(n = 40)。其他手术包括单纯搭桥术(n = 147)、搭桥联合血栓内膜切除术(n = 10)、搭桥联合血管内治疗(n = 6)、搭桥联合腰交感神经切除术(n = 2)、血管内治疗联合血栓内膜切除术(n = 4)、血管内治疗(n = 19)、腰交感神经切除术(n = 6)、保守治疗(n = 65)和大截肢术(n = 31)。我们还计算了P3风险评分,并在治疗前后测量了经皮氧分压(tcPO2)和皮肤灌注压(SPP)。
动脉重建组2年时肢体挽救率为87%。在低风险组(P3风险评分为3),1年无截肢生存率为96%。在中风险组(P3风险评分为4 - 7),1年无截肢生存率为88%。在高风险组(P3风险评分为8),1年无截肢生存率为66%。动脉重建组的医院死亡率为3.2%,所有死亡患者均为接受搭桥手术的患者。单纯保守治疗组5年生存率分别为65%和36%。144例患者中有140例溃疡愈合。4例感染未愈合患者治疗后tcPO2或SPP值超过30 mmHg。治疗后tcPO2或SPP值在20至30 mmHg之间的5例患者中有4例接受了大截肢术。治疗后tcPO2或SPP值低于20 mmHg的所有6例患者均接受了大截肢术。
在tcPO2或SPP值超过30 mmHg的病例中,溃疡可能愈合,但感染病例除外。我们建议,如果这些值低于30 mmHg,应进行完全血运重建。在本系列研究中,P3风险评分有助于预测肢体挽救情况。对于全身状况较差的患者,必须采用搭桥和血管内治疗的联合治疗方法。在肢体挽救方面尝试改善并通过充分的围手术期控制来控制手术死亡率非常重要。(《日本血管外科学杂志》2011年英文译文;20:905 - 911)